Pear Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Pear Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q4 2022.
Pear Therapeutics, Inc. Assets for the quarter ending December 31, 2022 was $95.1M, a 51.8% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2022	$95.1M	-$102M	-51.8%	Dec 31, 2022	10-K	2023-03-31
Q3 2022	$120M	-$157M	-56.8%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$143M	-$135M	-48.7%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$172M	-$105M	-38%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$197M	+$64.8M	+49%	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$277M			Sep 30, 2021	10-Q	2021-11-05
Q2 2021	$278M			Jun 30, 2021	10-Q	2021-08-19
Q1 2021	$277M			Mar 31, 2021	10-Q	2021-05-24
Q4 2020	$132M			Dec 31, 2020	10-K	2022-03-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.